Insider buying last 90 days
No open-market insider purchases were filed for NOVT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every NOVT insider filing, plotted on the chart in Gekko.Open NOVT in Gekko
NASDAQ: NOVT
Novanta (NOVT) Stock Analysis & Forecast
Sep 28 close
$142.08−1.85 (−1.3%)
Gekko Brief
AI summaryNovanta shares moved this week amid a sector-wide rally among scientific and technical instruments makers, with the stock surging 5.1% to close at $141.16 on one session, a move attributed to coordinated buying across the sector rather than company-specific news. Separate commentary placed shares 7.3% higher at $144.17, noting a GF Score of 88/100 driven by valuation and momentum. Novanta was also compared against peer Senstar Technologies on valuation, earnings, dividends, risk, and analyst recommendations.
As of 28 September, Novanta closes at $142.08, down 1.3%, sitting between its 50-day average of $147.21 and 200-day average of $139.89. The GekkoIndex reads 60.5, placing the stock in the Accumulation zone, though the index has fallen 9.6 over five days. Price sits 0.8% above Gekko Fair Value of $140.9.
Novanta's next earnings date falls on 2 November, 34 days out, beyond a typical 20-trading-day hold; the prior report on 5 August showed EPS of $0.89 against a $0.83 estimate, with a 2.4% reaction, and beats in 5 of the last 8 quarters. No insider, Congress, or unusual options activity appears in the current windows. Seasonally, the next 20 trading days have averaged a 6.3% gain over 5 years, rising in 3 of them. Analyst consensus among 2 firms rating the stock buy points to a $194.5 target.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Novanta price vs fair value
Close $142.08200-day averageGekko Fair Value $140.90
Novanta quick facts
- Market cap
- $5.06B
- P/E ratio
- 91.9
- Forward P/E
- 8.4
- EPS, TTM
- $1.54
- Revenue, TTM
- $1.03B
- Profit margin
- 6%
- Dividend yield
- —
- Beta
- 1.68
- Volume
- 298,948 avg 362,946
- 1-year return
- +38.3%
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±6.5%
- 50-day average
- $147.21
- 200-day average
- $139.89
- Next earnings
- Nov 2
- Shares outstanding
- 37.82M
Novanta swing-trade checklist
Novanta scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $142.08 sits between the 50-day ($147.21) and 200-day ($139.89) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
60.5, Accumulation
Reading 60.5 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
0.8% above
Price is within 5% of Gekko Fair Value (0.8% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 34 days
Next report Nov 2, 2026, 34 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+6.3% on average
From this point in the calendar, the next 20 trading days averaged +6.3% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Novanta stock chart and price history
Novanta closed at $142.08 on Sep 28, 2026, +38.3% over the past year, inside a 52-week range of $98.27 to $176.38.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −1.8%
- 3 months
- −9.9%
- 6 months
- +25.6%
- 1 year
- +38.3%
The full NOVT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open NOVT in Gekko
Follow Novanta through every session
Put NOVT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track NOVT in GekkoFree for 7 days. No credit card required.
About Novanta
Novanta designs and manufactures engineered components used inside larger equipment made by other manufacturers, with a focus on photonics, vision, and precision motion technology. Its parts and sub-assemblies serve original equipment manufacturers in the medical and industrial fields, and the company is recognized for building the specialized building blocks that go into imaging, laser, and motion-control equipment rather than selling finished products directly to end users.
The business is arranged into three segments. The photonics group makes laser-based systems, including scanning and beam-steering tools and several laser types, used in manufacturing, measurement, medical imaging, and applications like DNA sequencing. The vision group supplies medical instruments such as insufflators and pumps, visualization and wireless communication tools for operating rooms, plus machine vision, RFID, and spectrometry equipment. The precision motion group provides encoders, motors, servo drives, motion control systems, robotic end-effectors, and air bearings. Novanta reaches customers through a direct sales force along with resellers, distributors, and system integrators, and sells under a number of established brand names.
The company began in 1968 and previously operated as GSI Group before adopting the Novanta name in May 2016. It is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ under the ticker NOVT.
- Listed
- NASDAQ
- Sector
- Electronic technology
- Industry
- Electronic equipment/Instruments
- Website
- novanta.com
Novanta GekkoIndex: the smart money zone
Novanta’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.5, in the Accumulation zone, down 9.6 points over five sessions.
60.5Accumulation
Down 9.6 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +3.1% | +8.6% | ||
| Accumulation (current zone) | 258 | +0.1% | +0.5% | ||
| Neutral | 370 | −0.1% | −0.5% | ||
| Distribution | 17 | +0.2% | −4.1% | ||
| Selling | 1 | Too few readings yet | |||
Average NOVT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the NOVT price, zone by zone.Track NOVT in Gekko
Is Novanta stock overvalued? Gekko Fair Value
Novanta trades 0.8% above Gekko Fair Value of $140.90, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Novanta shares are worth, recalculated every trading day.
$140.90
Gekko Fair Value, Sep 26, 2026
0.8% above fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open NOVT in Gekko
Novanta insider and Congress trading
No open-market insider purchases were filed for Novanta, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in NOVT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for NOVT, plotted on the chart in Gekko.Open NOVT in Gekko
Buybacks
Novanta has been buying back its own shares.
- Bought back, quarter ended Jul 3, 2026
- $18.64M
- As a share of market cap
- 0.37%
- Trailing four quarters
- $70.69M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold NOVT.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Novanta earnings: next date and track record
Novanta reports on Nov 2, 2026 (34 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Nov 2, 2026
34 days away
- EPS estimate
- $0.97
- Revenue estimate
- $301.0M
5 of 8reports beat the EPS estimate
±5.9%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 5, 2026 AI summary
- What they said
- Novanta delivered Q2 2026 with 9% organic sales growth, 10% reported revenue growth, 16% adjusted EBITDA growth, and 47% adjusted gross margin (up 100bps YoY). Adjusted EPS grew 17% with YTD operating cash flow exceeding all of 2025. New product revenue surged 50%+ in Q2 and 60%+ YTD, lifting vitality index to 29%. The company closed its largest acquisition, Riverpoint Medical, expanding medical consumables to ~$300M annually.
- Guidance
- Following Riverpoint Medical close, Novanta raised full year 2026 outlook targeting more than 15% reported revenue growth YoY. Management expects continued strength in precision robotics, semiconductors, and minimally invasive surgery, with Riverpoint immediately accretive to margins and EPS.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $0.89 est $0.83 | $265.8M est $262.3M | +2.4% |
| May 11, 2026 | $0.51 est $0.83 | $257.7M est $253.4M | +15.1% |
| Feb 23, 2026 | $0.91 est $0.91 | $258.3M est $255.6M | −5.8% |
| Nov 3, 2025 | $0.87 est $0.84 | $247.8M est $255.6M | +1.8% |
| Aug 5, 2025 | $0.76 est $0.74 | $241.0M est $248.5M | −8.3% |
| May 6, 2025 | $0.59 est $0.67 | $233.4M est $240.7M | −0.9% |
| Feb 25, 2025 | $0.76 est $0.71 | $238.1M est $244.6M | +8.0% |
| Nov 5, 2024 | $0.85 est $0.85 | $244.4M est $240.3M | +4.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Novanta stock forecast and analyst price targets
Analysts’ average 12-month price target for Novanta is $194.50, +36.9% from the last close, from 2 firms rating the stock in the last 90 days.
$194.50consensus 12-month target, +36.9% from the last close
Each firm’s latest rating in the last 90 days: 2 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 7 | Robert W. Baird | $194 | +36.5% |
| Aug 6 | William Blair | — | — |
| Jul 31 | William Blair | — | — |
+0.5%average 20-day move after past Accumulation readings
+6.3%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Novanta seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Novanta averaged +6.3% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.9% | 4 of 5 |
| Next 10 trading days | −0.5% | 2 of 5 |
| Next 15 trading days | +2.3% | 3 of 5 |
| Next 20 trading days | +6.3% | 3 of 5 |
| Next 30 trading days | +4.2% | 4 of 5 |
For scale, NOVT’s typical 20-trading-day move in either direction is about 6.5%.
Novanta market cap and key statistics
Novanta’s market cap is $5.06B, with a P/E ratio of 91.9 and revenue of $1.03B over the last twelve months.
Valuation
- Market cap
- $5.06B
- P/E ratio
- 91.9
- Forward P/E
- 8.4
- EPS, TTM
- $1.54
- Gekko Fair Value
- $140.90
Trading
- Volume
- 298,948
- Avg volume, 20 days
- 362,946
- 52-week high
- $176.38
- 52-week low
- $98.27
- Shares outstanding
- 37.82M
Financials
- Revenue, TTM
- $1.03B
- Profit margin
- 6%
- Return on equity
- 5.1%
- Quarterly earnings growth, YoY
- +150.0%
Risk and income
- Beta
- 1.68
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±6.5%
Novanta stock news this week
3 headlines about Novanta from the past week, newest first, each linking to the publisher.
- Analyzing Senstar Technologies (NASDAQ:SNT) and Novanta (NASDAQ:NOVT)Defense World, Sep 24
- A Look at Novanta Inc (NOVT) After 7.3% Gain -- GF Value $156.35 vs Price $144.17GuruFocus, Sep 22
- Novanta Jumps 5.1% Amid Sector-Wide RallyAlphaStreet, Sep 22
Novanta peers
Novanta’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| EMREmerson Electric | Neutral | 14.8% above |
| KEYSKeysight Technologies | Neutral | 14.3% above |
| QQnity Electronics | Neutral | 3.4% below |
| FTVFortive | Accumulation | 3.6% below |
| ONTOOnto Innovation | Neutral | 2.1% above |
| NXTNextpower | Accumulation | 24.6% below |
A peer links to its own page where one exists.
Novanta stock FAQ
What is Novanta’s market cap?
Novanta’s market cap is $5.06B at the Sep 28, 2026 close of $142.08, with 37.82M shares outstanding. The shares trade on a P/E ratio of 91.9.
What is the Novanta stock forecast?
The consensus analyst 12-month price target for Novanta is $194.50, +36.9% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Novanta stock overvalued or undervalued?
On Gekko’s estimate Novanta is about fair value: the Sep 28, 2026 close of $142.08 is 0.8% above Gekko Fair Value of $140.90. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Novanta report earnings next?
Novanta is expected to report on Nov 2, 2026 (34 days away). Analysts expect earnings of $0.97 per share on revenue of $301.0M. Novanta beat the earnings estimate in 5 of its last 8 reports, moving 5.9% on average across the report.
What is Novanta’s 52-week high and low?
Novanta’s 52-week high is $176.38 and its 52-week low is $98.27; it closed at $142.08 on Sep 28, 2026, +38.3% over the past year. Over the last five years the shares peaked at $187.61 on Jun 30, 2023.
Is Novanta stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, earnings risk and seasonality), 2 as mixed (trend and fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Novanta the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.